Page 17 - Read Online

Page 12 of 13 Fearon et al. Metab Target Organ Damage 2022;2:13 https://dx.doi.org/10.20517/mtod.2022.12

2022;10:284-96. DOI PubMed
27. Griffin SB, Ross LJ, Burstow MJ, Desbrow B, Palmer MA. Efficacy of a dietitian-led very low calorie diet (VLCD) based model of
care to facilitate weight loss for obese patients prior to elective, non-bariatric surgery. J Hum Nutr Diet 2021;34:188-98. DOI
PubMed
28. Ruggenenti P, Abbate M, Ruggiero B, et al; C. RE.S.O. Study Group. Renal and systemic effects of calorie restriction in patients with
type 2 diabetes with abdominal obesity: a randomized controlled trial. Diabetes 2017;66:75-86. DOI
29. Holt RIG, Barnard-Kelly K, Dritsakis G, et al; OCTOPuS study group. Developing an intervention to optimise the outcome of cardiac
surgery in people with diabetes: the OCTOPuS pilot study. Pilot Feasibility Stud 2021;7:157. DOI PubMed PMC
30. Li S, Vandvik PO, Lytvyn L, et al. SGLT-2 inhibitors or GLP-1 receptor agonists for adults with type 2 diabetes: a clinical practice
guideline. BMJ 2021;373:n1091. DOI PubMed
31. Houlden RL, Yen JL, Moore S. Effectiveness of an interprofessional glycemic optimization clinic on preoperative glycated
hemoglobin levels for adult patients with type 2 diabetes undergoing bariatric surgery. Can J Diabetes 2018;42:514-9. DOI PubMed
32. Frías JP, Davies MJ, Rosenstock J, et al; SURPASS-2 Investigators. Tirzepatide versus semaglutide once weekly in patients with type
2 diabetes. N Engl J Med 2021;385:503-15. DOI PubMed
33. Jastreboff AM, Aronne LJ, Ahmad NN, et al; SURMOUNT-1 Investigators. Tirzepatide once weekly for the treatment of obesity. N
Engl J Med 2022;387:205-16. DOI PubMed
34. Rubino F, Nathan DM, Eckel RH, et al; Delegates of the 2nd Diabetes Surgery Summit. Metabolic surgery in the treatment algorithm
for type 2 diabetes: a joint statement by international diabetes organizations. Surg Obes Relat Dis 2016;12:1144-62. DOI PubMed
35. Lee Y, Dang JT, Switzer N, Malhan R, Birch DW, Karmali S. Bridging interventions before bariatric surgery in patients with BMI ≥
2
50 kg/m : a systematic review and meta-analysis. Surg Endosc 2019;33:3578-88. DOI PubMed
36. Kotinda APST, de Moura DTH, Ribeiro IB, et al. Efficacy of intragastric balloons for weight loss in overweight and obese adults: a
systematic review and meta-analysis of randomized controlled trials. Obes Surg 2020;30:2743-53. DOI PubMed
37. Abu Dayyeh BK, Maselli DB, Rapaka B, et al. Adjustable intragastric balloon for treatment of obesity: a multicentre, open-label,
randomised clinical trial. Lancet 2021;398:1965-73. DOI PubMed
38. Zorron R, Veltzke-Schlieker W, Adler A, et al. Endoscopic sleeve gastroplasty using Apollo Overstitch as a bridging procedure for
superobese and high risk patients. Endoscopy 2018;50:81-3. DOI PubMed
39. Abu Dayyeh BK, Bazerbachi F, Vargas EJ, et al. Endoscopic sleeve gastroplasty for treatment of class 1 and 2 obesity (MERIT): a
prospective, multicentre, randomised trial. Lancet 2022;400:441-51. DOI PubMed
40. Albaugh VL, Sharma G, Tu C, Aminian A. Clinical significance of diabetes control before metabolic surgery. Surg Obes Relat Dis
2021;17:1271-8. DOI PubMed
41. Umpierrez G, Cardona S, Pasquel F, et al. Randomized controlled trial of intensive versus conservative glucose control in patients
undergoing coronary artery bypass graft surgery: GLUCO-CABG trial. Diabetes Care 2015;38:1665-72. DOI PubMed PMC
42. Cardona S, Tsegka K, Pasquel FJ, et al. Sitagliptin for the prevention of stress hyperglycemia in patients without diabetes undergoing
coronary artery bypass graft (CABG) surgery. BMJ Open Diabetes Res Care 2019;7:e000703. DOI PubMed PMC
43. van den Boom W, Schroeder RA, Manning MW, Setji TL, Fiestan GO, Dunson DB. Effect of A1C and glucose on postoperative
mortality in noncardiac and cardiac surgeries. Diabetes Care 2018;41:782-8. DOI PubMed
44. Chiang HY, Lin KR, Hsiao YL, et al. Association between preoperative blood glucose level and hospital length of stay for patients
undergoing appendectomy or laparoscopic cholecystectomy. Diabetes Care 2021;44:107-15. DOI PubMed PMC
45. He T, Zhu W, Wang C, et al. Relationship between pre-operative blood glucose level and length of hospital stay in patients with renal
cell carcinoma undergoing laparoscopic nephrectomy. Front Surg 2021;8:659365. DOI PubMed PMC
46. Domek N, Dux K, Pinzur M, Weaver F, Rogers T. Association between hemoglobin a1c and surgical morbidity in elective foot and
ankle surgery. J Foot Ankle Surg 2016;55:939-43. DOI PubMed
47. Gustafsson UO, Thorell A, Soop M, Ljungqvist O, Nygren J. Haemoglobin A1c as a predictor of postoperative hyperglycaemia and
complications after major colorectal surgery. Br J Surg 2009;96:1358-64. DOI PubMed
48. O'Sullivan CJ, Hynes N, Mahendran B, et al. Haemoglobin A1c (HbA1C) in non-diabetic and diabetic vascular patients. Is HbA1C an
independent risk factor and predictor of adverse outcome? Eur J Vasc Endovasc Surg 2006;32:188-97. DOI PubMed
49. Vilar-Compte D, Alvarez de Iturbe I, Martín-Onraet A, Pérez-Amador M, Sánchez-Hernández C, Volkow P. Hyperglycemia as a risk
factor for surgical site infections in patients undergoing mastectomy. Am J Infect Control 2008;36:192-8. DOI PubMed
50. Makino H, Tanaka A, Asakura K, et al. Addition of low-dose liraglutide to insulin therapy is useful for glycaemic control during the
peri-operative period: effect of glucagon-like peptide-1 receptor agonist therapy on glycaemic control in patients undergoing cardiac
surgery (GLOLIA study). Diabet Med 2019;36:1621-8. DOI PubMed
51. Hulst AH, Visscher MJ, Godfried MB, et al; GLOBE Study Group. Liraglutide for perioperative management of hyperglycaemia in
cardiac surgery patients: a multicentre randomized superiority trial. Diabetes Obes Metab 2020;22:557-65. DOI PubMed PMC
52. Kaneko S, Ueda Y, Tahara Y. GLP1 receptor agonist liraglutide is an effective therapeutic option for perioperative glycemic control in
type 2 diabetes within Enhanced Recovery After Surgery (ERAS) protocols. Eur Surg Res 2018;59:349-60. DOI PubMed
53. Draznin B, Aroda VR, Bakris G, et al; American Diabetes Association Professional Practice Committee. , American Diabetes
Association Professional Practice Committee:. 16. Diabetes care in the hospital: standards of medical care in diabetes-2022. Diabetes
Care 2022;45:S244-53. DOI PubMed
54. Duggan E, Chen Y. Glycemic management in the operating room: screening, monitoring, oral hypoglycemics, and insulin therapy.